Skip to main content
Fig. 4 | BMC Complementary Medicine and Therapies

Fig. 4

From: Anti-obesity effect of Neoagaro-oligosaccharides with overweight and obese subjects: a 16-week, randomized, double-blind, placebo-controlled clinical trial

Fig. 4

Change in body fat areas. (A) Visceral fat area(VFA), (B) Visceral-subcutaneous fat ratio(VSR) were measured in NAOs and placebo treated groups at baseline and 16 weeks. Values are pre-sented as mean ± SD. Between-group differences were assessed using independent t-test for change value between the groups. *p < 0.05 vs. placebo group. NAOs, Neoagaro-oligosaccharides; VFA, visceral fat area; VSR, visceral-subcutaneous fat area ratio

Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us